CDKN2A and meningioma: In case of aggressive atypical meningiomas and meningiomas with borderline grades 2–3 histopathology, genetic analyses have revealed that TERTp mutation and homozygous CDKN2A/B loss should be looked for and when present indicate a grade 3 tumour [16, 27].